Mitochem Therapeutics Company

MitoChem Therapeutics is a privately held company developing mitochondrial targeted small molecules for ophthalmic and neurodegenerative diseases. Mitochem has used high-throughput screening and sophisticated secondary assays, medicinal chemistry optimization and computational strategies to develop small molecules that protect mitochondria that are undergoing the stress that drives neuropathologies and diseases.
Industry: Small&Large Molecules
Headquarters: Charleston, South Carolina, United States
Founded Date: 2011

Visit Website
Register and Claim Ownership